JAKAVI 5MG TABLET
Form: Tablets
Pack Size: 10 TABLETS
Marketed by: NOVARTIS HEALTHCARE PVT LTD (ONCOLOGY DIV)
MRP: ₹26750.00
NOVARTIS HEALTHCARE PVT LTD (ONCOLOGY DIV): Jakavi 5MG Tablet, 10 tablets, salt ruxolitinib 5mg. Its MRP stays at Rs 26,750 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 20,380.95. Group: JAK1/JAK2 inhibitor (targeted therapy). No other manufacturer of this salt and strength is listed here yet. Handling/counselling: do not stop suddenly - symptoms can rebound. Schedule H - supply only to licensed buyers and dispense only on prescription.
Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.